Genetic Signatures Limited (ASX:GSS)
0.0950
-0.0050 (-5.00%)
At close: Mar 6, 2026
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 21.58 million as of March 6, 2026. Its market cap has decreased by -83.33% in one year.
Market Cap
21.58M
Enterprise Value
-7.73M
Revenue
19.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 21.58M, a decrease of -39.00%. That is a compound annual growth rate of -4.42%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BCAL Diagnostics | 44.17M |
| INOVIQ | 47.86M |
| Microba Life Sciences | 51.76M |
| Imagion Biosystems | 9.81M |
| Rhythm Biosciences | 59.02M |
| Cryosite | 60.77M |
| Genetic Technologies | 5.67M |
| Monash IVF Group | 253.26M |